Status:
WITHDRAWN
Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer
Lead Sponsor:
Pfizer
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Gemcitabine and cisplatin given together is a standard treatment option for advanced lung cancer patients. The purpose of this study is to assess if the life span is longer in patients taking the inve...
Eligibility Criteria
Inclusion
- Non-Small Cell Lung Cancer (NSCLC), advanced, chemotherapy-naive
- Male or female \> 18 years
- Eastern Oncology Cooperative Group (ECOG) Performance Status (PS) 0 or 1
- Adequate organ function
Exclusion
- Uncontrolled hypertension or diabetes;
- Pregnant female;
- Symptomatic Central Nervous System (CNS) metastasis, requirement for chronic corticosteroids.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00907504
Start Date
July 1 2010
End Date
May 1 2014
Last Update
June 17 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.